| Financial Year |
March 31 2023 |
| Monetary Funds |
10,767,536,086.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
301,632,525.50 |
| Advances to Suppliers |
240,772,634.50 |
| Other Receivables |
156,238,955.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,827,421,605.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
33,600,203.69 |
| Other Current Assets |
259,512,542.00 |
| Total Current Assets |
13,588,070,552.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
63,354,734.16 |
| Long-term Equity Investment |
1,884,070,737.06 |
| Investment Properties |
1,449,443,252.36 |
| Fixed Assetes |
8,108,379,324.39 |
| Under-construction Projects |
286,489,958.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,128,749,686.75 |
| R&D expenses |
-- |
| Goodwill |
1,225,274,370.13 |
| Long-Term Deferred and Prepaid Expenses |
815,169,182.98 |
| Deferred Income Tax Assets |
1,518,342,122.57 |
| Other Non-Current Assets |
1,345,267,271.05 |
| Sub-Total of Non-Current Assets |
25,206,835,708.49 |
| Total Assets |
38,794,906,260.72 |
| Short-Term Loans |
227,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,719,835,802.84 |
| Accounts Received In Advance |
79,129,719.97 |
| Employee Compensation Payable |
181,903,077.30 |
| Taxes Payable |
185,297,111.38 |
| Interest Payable |
-- |
| Dividend Payable |
5,060,995.73 |
| Other payables |
2,989,044,116.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
963,959,524.93 |
| Other Current Liabilities |
257,671,528.87 |
| Sub-Total of Current Liabilities |
8,332,738,376.90 |
| Long-term Loans |
738,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
65,751,539.63 |
| Deferred Income Tax Liabilities |
1,611,575,777.07 |
| Other Non-Current Liabilities |
20,409,590.88 |
| Sub-Total of Non-Current Liabilities |
10,282,413,523.25 |
| Total Liabilities |
18,615,151,900.15 |
| Paid-In Capital(Or Share Stock) |
1,135,049,451.00 |
| Capital Surplus |
10,164,333,551.31 |
| Surplus Reserve |
2,158,734,219.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,914,592,398.08 |
| Minority Stockholder's Interest |
807,029,947.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,372,724,413.40 |
| Owner's Equity（Stockholder's Equity） |
20,179,754,360.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,794,906,260.72 |
